Data as of Nov 26
| +0.19 / +0.65%|
The 3 analysts offering 12-month price forecasts for Medifast Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 27.86. The median estimate represents a +1.21% increase from the last price of 29.64.
The current consensus among 3 polled investment analysts is to Hold stock in Medifast Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.